Comparison of the efficacy of Azithromycin and Doxycycline in treatment of acne

Comparison of the efficacy of Azithromycin and Doxycycline in cases of moderate intensity inflammatory papulopustular acne, a randomized clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100102002954N16

Enrollment

140

Registered

2019-09-15

Start date

2019-09-06

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne conglobata. Acne conglobata

Interventions

Intervention 1: Intervention group: Using Azithromysin tablet (Pars darou Company) in a single dose (250 mg/day) orally for three months in addition using topical Tertinoin lotion 0.05% (Alborz compan

Eligibility

Sex/Gender

All

Age

15 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with moderate inflammatory papulopustular acne, Age range 15-50 years, Satisfaction with the research.

Exclusion criteria

Exclusion criteria: Previous burns, Severe hormonal disorders such as hypothyroidism, Chronic liver and kidney disease, Pregnancy and lactation, doing restorative skin care like laser

Design outcomes

Primary

Measure	Time frame
Acne healing speed. Timepoint: Once every two weeks. Method of measurement: Skin imaging and global response assessment.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Mohammad Bagher Sohrabi

Shahroud University of Medical Sciences

mb.sohrabi@shmu.ac.ir+98 23 3234 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026